Skip to content
Screener

Kestra Medical Technologies KMTS Other Income (Expense)

Other Income (Expense) at other companies

Abbott logo
AbbottABT
$134M-2.2%
Medtronic logo
MedtronicMDT
$137M
iRhythm Holdings, Inc. logo
iRhythm Holdings, Inc.IRTC
$2.16M-49.8%
CeriBell, Inc. logo
CeriBell, Inc.CBLL
$1.15M-35.6%
Haemonetics logo
HaemoneticsHAE
-$9.88M-13.6%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$9.39M+405%

Other financials

Income statement

See full
Revenue$28.6M+66.2%
Gross profit$15.7M+105%
Operating income-$39.3M+18.4%
Net income-$38.8M+25.4%
EPS (diluted)-$0.67+57.3%

Balance sheet

See full
Cash & equivalents$99.7M-58.0%
Total debt$46.8M+5.6%
Total assets$358.5M+21.2%

Cash flow

See full
Operating cash flow-$18.7M+22.2%
CapEx$9.7M+30.8%
Free cash flow-$28.4M+9.7%

Valuation

See full
Market cap$1.55B+106%
Enterprise value$1.49B+151%
P/S16.3×+4.9×

Profitability

See full
Gross margin51.4%+10.9pp
Operating margin-141.6%-24.0pp
Net margin-138.4%-29.7pp
FCF margin-122.6%-26.1pp

Returns & leverage

See full
Current ratio4.4×-2.3×

Where this comes from

Reported directly by Kestra Medical Technologies in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: Kestra Medical Technologies’s 10-K, filed July 14, 2026.

Filed
Jul 14, 2026, 5:16 PM EDT
Fiscal year
FY2026
Accession
0001193125-26-303397
Line itemYear Ended April 30, 2026Year Ended April 30, 2025
Other expense (income):
Interest expense7,5467,734
Interest income(8,351)(3,199)
Other expense (income)(2,618)2,766
Net loss before provision for income taxes(131,318)(113,679)
Provision for income taxes294135
Net loss(131,612)(113,814)
Less: Undeclared preferred stock dividends12,321

Item 16. Form 10-K Summary.

FAQ

What is Kestra Medical Technologies's other income (expense)?
Kestra Medical Technologies (KMTS) reported other income (expense) of $319K in Q1 2026.
How has Kestra Medical Technologies's other income (expense) changed year-over-year?
Kestra Medical Technologies's other income (expense) increased by 111.8% year-over-year, from -$2.69M to $319K.
What is the long-term trend for Kestra Medical Technologies's other income (expense)?
Over 2 years (2024 to 2026), Kestra Medical Technologies's other income (expense) has grown at a -3.4% compound annual growth rate (CAGR), from -$2.8M to $2.62M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Ask your AI about Kestra Medical Technologies's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude